Aldeyra Therapeutics Announces Positive Results From Phase II Clinical Trial in Subjects With Noninfectious Anterior Uveitis
Company to Provide Corporate Update and First Quarter Financial Results Announcement of the Second Positive Phase II Clinical Trial of NS2 in 2016 NS2 Has Now Demonstrated Clinical Activity in the Two Major Types of Ocular Inflammation LEXINGTON, MA -- ( …